Methylnaphthidate
| HDMP-28 | |
|---|---|
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 283.4 g/mol [1] |
| Predicted LogP | 1.5 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C18H21NO2 [1] |
| IUPAC name | methyl 2-naphthalen-2-yl-2-piperidin-2-ylacetate [1] |
| SMILES | COC(=O)C(C1CCCCN1)C2=CC3=CC=CC=C3C=C2 [1] |
| InChI | InChI=1S/C18H21NO2/c1-21-18(20)17(16-8-4-5-11-19-16)15-10-9-13-6-2-3-7-14(13)12-15/h2-3,6-7,9-10,12,16-17,19H,4-5,8,11H2,1H3 [1] |
| InChIKey | DNRNSIJBSCBESJ-UHFFFAOYSA-N [1] |
Methylnaphthidate (also known as Schembl15655519 or NS00018064) is a
Chemistry
Stereochemistry []
Methylnaphthidate is a racemic mixture of the diastereomers.
| Stereoisomerism |
|---|
| Stereoisomer enumberation with rdkit |
Subjective effects []
Experience reports []
There are currently 4 experience reports involving methylnaphthidate on Erowid:
Legal status []
- Canada: Methylnaphthidate is a Schedule III substance.
- Germany: Methylnaphthidate is a Neuer-Psychoaktiver-Stoff under the "Neue-psychoaktive-Stoffe-Gesetz (NpSG)".
- United Kingdom: Methylnaphthidate is a Class B substance.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 49823708, Schembl15655519. Accessed May 8, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/49823708